Health and Medicine Media

Drugs to combat anemia associated with chemotherapy and chronic kidney disease increase risk of venous thromboembolism.

The controversy over Procrit and Aranesp, two drugs used to combat anemia associated with chemotherapy and chronic kidney disease, continues to increase, because new research indicates that increase the risk of venous thromboembolism is the formation of potentially fatal blood clots .

Recent studies have linked these drugs, called erythropoietic stimulating agents (ESA), with an increased risk of death, stroke, and new cancers.

Read the rest of this entry »